HEADER ONCOPROTEIN 21-MAR-24 9B4S TITLE CRYSTAL STRUCTURE OF THE RRAS2-P110ALPHA COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC COMPND 3 SUBUNIT ALPHA ISOFORM; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: PI3-KINASE SUBUNIT ALPHA,PI3K-ALPHA,PI3KALPHA,PTDINS-3- COMPND 6 KINASE SUBUNIT ALPHA,PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE COMPND 7 110 KDA CATALYTIC SUBUNIT ALPHA,PTDINS-3-KINASE SUBUNIT P110-ALPHA, COMPND 8 P110ALPHA,PHOSPHOINOSITIDE 3-KINASE ALPHA,PHOSPHOINOSITIDE-3-KINASE COMPND 9 CATALYTIC ALPHA POLYPEPTIDE,SERINE/THREONINE PROTEIN KINASE PIK3CA; COMPND 10 EC: 2.7.1.137,2.7.1.153,2.7.11.1; COMPND 11 ENGINEERED: YES; COMPND 12 MUTATION: YES; COMPND 13 MOL_ID: 2; COMPND 14 MOLECULE: RAS-RELATED PROTEIN R-RAS2; COMPND 15 CHAIN: B; COMPND 16 SYNONYM: RAS-LIKE PROTEIN TC21,TERATOCARCINOMA ONCOGENE; COMPND 17 EC: 3.6.5.-; COMPND 18 ENGINEERED: YES; COMPND 19 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PIK3CA; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLACEA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 3043702; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: RRAS2, TC21; SOURCE 13 EXPRESSION_SYSTEM: TRICHOPLACEA; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 3043702 KEYWDS RAS, RRAS2, TC21, P110ALPHA, PIK3CA, PI3KALPHA, ONCOPROTEIN, PI3KA, KEYWDS 2 PI3K EXPDTA X-RAY DIFFRACTION AUTHOR D.J.CZYZYK,D.K.SIMANSHU REVDAT 1 22-JAN-25 9B4S 0 JRNL AUTH D.CZYZYK,W.YAN,S.MESSING,W.GILLETTE,T.TSUJI,M.YAMAGUCHI, JRNL AUTH 2 S.FURUZONO,D.M.TURNER,D.ESPOSITO,D.V.NISSLEY,F.MCCORMICK, JRNL AUTH 3 D.K.SIMANSHU JRNL TITL STRUCTURAL INSIGHTS INTO ISOFORM-SPECIFIC RAS-PI3K ALPHA JRNL TITL 2 INTERACTIONS AND THE ROLE OF RAS IN PI3K ALPHA ACTIVATION. JRNL REF NAT COMMUN V. 16 525 2025 JRNL REFN ESSN 2041-1723 JRNL PMID 39788953 JRNL DOI 10.1038/S41467-024-55766-X REMARK 2 REMARK 2 RESOLUTION. 3.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.21_5207: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.26 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 3 NUMBER OF REFLECTIONS : 28056 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.232 REMARK 3 R VALUE (WORKING SET) : 0.230 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1404 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 49.2600 - 6.6800 0.92 2768 146 0.1912 0.2148 REMARK 3 2 6.6700 - 5.3000 0.94 2685 142 0.2572 0.2903 REMARK 3 3 5.3000 - 4.6300 0.94 2648 140 0.2110 0.2609 REMARK 3 4 4.6300 - 4.2100 0.95 2651 139 0.2147 0.2652 REMARK 3 5 4.2100 - 3.9100 0.95 2668 140 0.2537 0.2693 REMARK 3 6 3.9100 - 3.6800 0.95 2642 140 0.2481 0.3711 REMARK 3 7 3.6800 - 3.4900 0.96 2664 140 0.2791 0.3491 REMARK 3 8 3.4900 - 3.3400 0.96 2629 138 0.3176 0.3812 REMARK 3 9 3.3400 - 3.2100 0.96 2655 140 0.3417 0.3819 REMARK 3 10 3.2100 - 3.1000 0.96 2642 139 0.3441 0.4087 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.560 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.140 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.001 8768 REMARK 3 ANGLE : 0.385 11859 REMARK 3 CHIRALITY : 0.038 1297 REMARK 3 PLANARITY : 0.003 1516 REMARK 3 DIHEDRAL : 10.730 3320 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -42.8857 -9.2009 -21.0239 REMARK 3 T TENSOR REMARK 3 T11: 0.9559 T22: 0.9217 REMARK 3 T33: 1.0302 T12: -0.0450 REMARK 3 T13: -0.2052 T23: 0.1949 REMARK 3 L TENSOR REMARK 3 L11: 1.3499 L22: 2.5771 REMARK 3 L33: 1.2268 L12: 1.1936 REMARK 3 L13: -0.8216 L23: -0.7089 REMARK 3 S TENSOR REMARK 3 S11: 0.2977 S12: 0.0912 S13: -0.1232 REMARK 3 S21: 0.6710 S22: -0.2061 S23: -0.5331 REMARK 3 S31: -0.1625 S32: -0.2750 S33: -0.0822 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9B4S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-MAR-24. REMARK 100 THE DEPOSITION ID IS D_1000282603. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-JUL-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 S 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28076 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.100 REMARK 200 RESOLUTION RANGE LOW (A) : 49.260 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 200 DATA REDUNDANCY : 9.300 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.1200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.29 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 2.03800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M (BICINE/TRIS), 0.06 M DIVALENT REMARK 280 MIX, 30% (40%V/V PEG MME 500, 20%W/V PEG 20000), PH 8.5, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 42 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y+1/2,X+1/2,Z+1/2 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/2 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 90.74400 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 90.74400 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 48.01500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 90.74400 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 90.74400 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 48.01500 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 90.74400 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 90.74400 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 48.01500 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 90.74400 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 90.74400 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 48.01500 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 104 REMARK 465 VAL A 105 REMARK 465 GLY A 106 REMARK 465 ILE A 311 REMARK 465 SER A 312 REMARK 465 THR A 313 REMARK 465 ALA A 314 REMARK 465 THR A 315 REMARK 465 PRO A 316 REMARK 465 TYR A 317 REMARK 465 MET A 318 REMARK 465 ASN A 319 REMARK 465 GLY A 320 REMARK 465 GLU A 321 REMARK 465 THR A 322 REMARK 465 VAL A 344 REMARK 465 ASN A 345 REMARK 465 VAL A 346 REMARK 465 ASN A 347 REMARK 465 ILE A 348 REMARK 465 ARG A 349 REMARK 465 ASP A 350 REMARK 465 ILE A 351 REMARK 465 ASP A 352 REMARK 465 GLY A 411 REMARK 465 ARG A 412 REMARK 465 LYS A 413 REMARK 465 GLY A 414 REMARK 465 ALA A 415 REMARK 465 ALA A 504 REMARK 465 GLY A 505 REMARK 465 PHE A 506 REMARK 465 SER A 507 REMARK 465 TYR A 508 REMARK 465 SER A 509 REMARK 465 HIS A 510 REMARK 465 ALA A 511 REMARK 465 GLY A 512 REMARK 465 LEU A 513 REMARK 465 SER A 514 REMARK 465 ASN A 515 REMARK 465 ARG A 516 REMARK 465 LEU A 517 REMARK 465 ALA A 518 REMARK 465 ARG A 519 REMARK 465 ASP A 520 REMARK 465 ASN A 521 REMARK 465 GLU A 522 REMARK 465 LYS A 863 REMARK 465 GLY A 864 REMARK 465 GLY A 865 REMARK 465 LEU A 866 REMARK 465 LYS A 867 REMARK 465 GLY A 868 REMARK 465 ALA A 869 REMARK 465 LEU A 870 REMARK 465 GLN A 871 REMARK 465 LYS A 942 REMARK 465 LYS A 943 REMARK 465 LYS A 944 REMARK 465 PHE A 945 REMARK 465 GLY A 946 REMARK 465 TYR A 947 REMARK 465 LYS A 948 REMARK 465 ARG A 949 REMARK 465 GLU A 950 REMARK 465 ARG A 951 REMARK 465 LYS A 1054 REMARK 465 MET A 1055 REMARK 465 ASP A 1056 REMARK 465 ALA A 1057 REMARK 465 ALA A 1058 REMARK 465 ALA A 1059 REMARK 465 HIS A 1060 REMARK 465 THR A 1061 REMARK 465 ILE A 1062 REMARK 465 LYS A 1063 REMARK 465 GLN A 1064 REMARK 465 HIS A 1065 REMARK 465 ALA A 1066 REMARK 465 LEU A 1067 REMARK 465 ASN A 1068 REMARK 465 GLY B 0 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 ALA B 3 REMARK 465 ALA B 4 REMARK 465 GLY B 5 REMARK 465 TRP B 6 REMARK 465 ARG B 7 REMARK 465 ASP B 8 REMARK 465 GLY B 9 REMARK 465 SER B 10 REMARK 465 GLY B 11 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 148 CG CD CE NZ REMARK 470 ILE A 181 CD1 REMARK 470 ILE A 211 CD1 REMARK 470 LYS A 353 CG CD CE NZ REMARK 470 GLN A 374 CG CD OE1 NE2 REMARK 470 ASN A 380 CG OD1 ND2 REMARK 470 ILE A 391 CD1 REMARK 470 ARG A 502 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 503 CG CD OE1 OE2 REMARK 470 ILE A 543 CD1 REMARK 470 ILE A 561 CD1 REMARK 470 ILE A 564 CD1 REMARK 470 LYS A 776 CG CD CE NZ REMARK 470 PHE A 872 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ILE A 913 CD1 REMARK 470 LYS A 941 CG CD CE NZ REMARK 470 PHE A 954 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN A 958 CG CD OE1 NE2 REMARK 470 LYS A 966 CG CD CE NZ REMARK 470 ARG A1023 CZ NH1 NH2 REMARK 470 LYS B 177 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 170 95.73 -67.12 REMARK 500 VAL A 198 -64.22 -106.46 REMARK 500 ASP A 214 41.62 -93.41 REMARK 500 ARG A 230 -115.20 59.88 REMARK 500 MET A 232 -150.31 -108.26 REMARK 500 SER A 236 2.67 -69.28 REMARK 500 LYS A 249 -33.71 -134.16 REMARK 500 ILE A 251 -166.96 -119.46 REMARK 500 LYS A 264 36.47 -82.57 REMARK 500 SER A 308 36.88 -99.25 REMARK 500 THR A 324 70.64 54.57 REMARK 500 LEU A 339 -73.35 -81.17 REMARK 500 TRP A 383 -62.48 -136.29 REMARK 500 ALA A 399 31.31 -99.23 REMARK 500 LEU A 422 -52.55 -139.63 REMARK 500 PRO A 449 -175.05 -69.26 REMARK 500 GLU A 453 -69.73 -92.50 REMARK 500 PRO A 466 31.61 -89.08 REMARK 500 LYS A 468 19.48 47.34 REMARK 500 PHE A 480 -1.25 68.13 REMARK 500 LYS A 723 -127.77 56.29 REMARK 500 GLN A 728 -66.22 -132.40 REMARK 500 LYS A 733 -71.41 -91.48 REMARK 500 SER A 774 -159.11 -93.78 REMARK 500 ARG A 777 76.44 53.44 REMARK 500 PRO A 786 2.75 -68.66 REMARK 500 LEU A 793 -168.28 -102.14 REMARK 500 ASP A 843 -72.68 -72.41 REMARK 500 HIS A 917 -167.15 -109.68 REMARK 500 ASP A 933 72.15 57.93 REMARK 500 HIS A 940 -11.15 -148.45 REMARK 500 LYS A 966 -112.89 53.83 REMARK 500 GLU A 970 -89.61 -118.61 REMARK 500 THR A 974 -161.57 -118.99 REMARK 500 HIS A1048 103.43 -55.74 REMARK 500 TRP A1051 60.98 -115.04 REMARK 500 ILE B 35 -65.11 -105.27 REMARK 500 TYR B 43 76.86 -113.30 REMARK 500 ILE B 47 -63.99 -107.02 REMARK 500 GLU B 48 110.07 -164.46 REMARK 500 GLU B 73 -8.69 65.00 REMARK 500 GLN B 81 -60.71 -95.34 REMARK 500 MET B 154 118.44 -160.98 REMARK 500 PHE B 178 -75.65 -86.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 202 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER B 28 OG REMARK 620 2 THR B 46 OG1 75.8 REMARK 620 3 GNP B 201 O2G 135.9 93.7 REMARK 620 4 GNP B 201 O2B 82.4 157.6 105.5 REMARK 620 N 1 2 3 DBREF 9B4S A 105 1068 UNP P42336 PK3CA_HUMAN 105 1068 DBREF 9B4S B 1 179 UNP P62070 RRAS2_HUMAN 1 179 SEQADV 9B4S GLY A 104 UNP P42336 EXPRESSION TAG SEQADV 9B4S ALA A 1057 UNP P42336 TRP 1057 ENGINEERED MUTATION SEQADV 9B4S ALA A 1058 UNP P42336 ILE 1058 ENGINEERED MUTATION SEQADV 9B4S ALA A 1059 UNP P42336 PHE 1059 ENGINEERED MUTATION SEQADV 9B4S GLY B 0 UNP P62070 EXPRESSION TAG SEQADV 9B4S ALA B 36 UNP P62070 GLN 36 ENGINEERED MUTATION SEQRES 1 A 965 GLY VAL GLY ASN ARG GLU GLU LYS ILE LEU ASN ARG GLU SEQRES 2 A 965 ILE GLY PHE ALA ILE GLY MET PRO VAL CYS GLU PHE ASP SEQRES 3 A 965 MET VAL LYS ASP PRO GLU VAL GLN ASP PHE ARG ARG ASN SEQRES 4 A 965 ILE LEU ASN VAL CYS LYS GLU ALA VAL ASP LEU ARG ASP SEQRES 5 A 965 LEU ASN SER PRO HIS SER ARG ALA MET TYR VAL TYR PRO SEQRES 6 A 965 PRO ASN VAL GLU SER SER PRO GLU LEU PRO LYS HIS ILE SEQRES 7 A 965 TYR ASN LYS LEU ASP LYS GLY GLN ILE ILE VAL VAL ILE SEQRES 8 A 965 TRP VAL ILE VAL SER PRO ASN ASN ASP LYS GLN LYS TYR SEQRES 9 A 965 THR LEU LYS ILE ASN HIS ASP CYS VAL PRO GLU GLN VAL SEQRES 10 A 965 ILE ALA GLU ALA ILE ARG LYS LYS THR ARG SER MET LEU SEQRES 11 A 965 LEU SER SER GLU GLN LEU LYS LEU CYS VAL LEU GLU TYR SEQRES 12 A 965 GLN GLY LYS TYR ILE LEU LYS VAL CYS GLY CYS ASP GLU SEQRES 13 A 965 TYR PHE LEU GLU LYS TYR PRO LEU SER GLN TYR LYS TYR SEQRES 14 A 965 ILE ARG SER CYS ILE MET LEU GLY ARG MET PRO ASN LEU SEQRES 15 A 965 MET LEU MET ALA LYS GLU SER LEU TYR SER GLN LEU PRO SEQRES 16 A 965 MET ASP CYS PHE THR MET PRO SER TYR SER ARG ARG ILE SEQRES 17 A 965 SER THR ALA THR PRO TYR MET ASN GLY GLU THR SER THR SEQRES 18 A 965 LYS SER LEU TRP VAL ILE ASN SER ALA LEU ARG ILE LYS SEQRES 19 A 965 ILE LEU CYS ALA THR TYR VAL ASN VAL ASN ILE ARG ASP SEQRES 20 A 965 ILE ASP LYS ILE TYR VAL ARG THR GLY ILE TYR HIS GLY SEQRES 21 A 965 GLY GLU PRO LEU CYS ASP ASN VAL ASN THR GLN ARG VAL SEQRES 22 A 965 PRO CYS SER ASN PRO ARG TRP ASN GLU TRP LEU ASN TYR SEQRES 23 A 965 ASP ILE TYR ILE PRO ASP LEU PRO ARG ALA ALA ARG LEU SEQRES 24 A 965 CYS LEU SER ILE CYS SER VAL LYS GLY ARG LYS GLY ALA SEQRES 25 A 965 LYS GLU GLU HIS CYS PRO LEU ALA TRP GLY ASN ILE ASN SEQRES 26 A 965 LEU PHE ASP TYR THR ASP THR LEU VAL SER GLY LYS MET SEQRES 27 A 965 ALA LEU ASN LEU TRP PRO VAL PRO HIS GLY LEU GLU ASP SEQRES 28 A 965 LEU LEU ASN PRO ILE GLY VAL THR GLY SER ASN PRO ASN SEQRES 29 A 965 LYS GLU THR PRO CYS LEU GLU LEU GLU PHE ASP TRP PHE SEQRES 30 A 965 SER SER VAL VAL LYS PHE PRO ASP MET SER VAL ILE GLU SEQRES 31 A 965 GLU HIS ALA ASN TRP SER VAL SER ARG GLU ALA GLY PHE SEQRES 32 A 965 SER TYR SER HIS ALA GLY LEU SER ASN ARG LEU ALA ARG SEQRES 33 A 965 ASP ASN GLU LEU ARG GLU ASN ASP LYS GLU GLN LEU LYS SEQRES 34 A 965 ALA ILE SER THR ARG ASP PRO LEU SER GLU ILE THR GLU SEQRES 35 A 965 GLN GLU LYS ASP PHE LEU TRP SER HIS ARG HIS TYR CYS SEQRES 36 A 965 VAL THR ILE PRO GLU ILE LEU PRO LYS LEU LEU LEU SER SEQRES 37 A 965 VAL LYS TRP ASN SER ARG ASP GLU VAL ALA GLN MET TYR SEQRES 38 A 965 CYS LEU VAL LYS ASP TRP PRO PRO ILE LYS PRO GLU GLN SEQRES 39 A 965 ALA MET GLU LEU LEU ASP CYS ASN TYR PRO ASP PRO MET SEQRES 40 A 965 VAL ARG GLY PHE ALA VAL ARG CYS LEU GLU LYS TYR LEU SEQRES 41 A 965 THR ASP ASP LYS LEU SER GLN TYR LEU ILE GLN LEU VAL SEQRES 42 A 965 GLN VAL LEU LYS TYR GLU GLN TYR LEU ASP ASN LEU LEU SEQRES 43 A 965 VAL ARG PHE LEU LEU LYS LYS ALA LEU THR ASN GLN ARG SEQRES 44 A 965 ILE GLY HIS PHE PHE PHE TRP HIS LEU LYS SER GLU MET SEQRES 45 A 965 HIS ASN LYS THR VAL SER GLN ARG PHE GLY LEU LEU LEU SEQRES 46 A 965 GLU SER TYR CYS ARG ALA CYS GLY MET TYR LEU LYS HIS SEQRES 47 A 965 LEU ASN ARG GLN VAL GLU ALA MET GLU LYS LEU ILE ASN SEQRES 48 A 965 LEU THR ASP ILE LEU LYS GLN GLU LYS LYS ASP GLU THR SEQRES 49 A 965 GLN LYS VAL GLN MET LYS PHE LEU VAL GLU GLN MET ARG SEQRES 50 A 965 ARG PRO ASP PHE MET ASP ALA LEU GLN GLY PHE LEU SER SEQRES 51 A 965 PRO LEU ASN PRO ALA HIS GLN LEU GLY ASN LEU ARG LEU SEQRES 52 A 965 GLU GLU CYS ARG ILE MET SER SER ALA LYS ARG PRO LEU SEQRES 53 A 965 TRP LEU ASN TRP GLU ASN PRO ASP ILE MET SER GLU LEU SEQRES 54 A 965 LEU PHE GLN ASN ASN GLU ILE ILE PHE LYS ASN GLY ASP SEQRES 55 A 965 ASP LEU ARG GLN ASP MET LEU THR LEU GLN ILE ILE ARG SEQRES 56 A 965 ILE MET GLU ASN ILE TRP GLN ASN GLN GLY LEU ASP LEU SEQRES 57 A 965 ARG MET LEU PRO TYR GLY CYS LEU SER ILE GLY ASP CYS SEQRES 58 A 965 VAL GLY LEU ILE GLU VAL VAL ARG ASN SER HIS THR ILE SEQRES 59 A 965 MET GLN ILE GLN CYS LYS GLY GLY LEU LYS GLY ALA LEU SEQRES 60 A 965 GLN PHE ASN SER HIS THR LEU HIS GLN TRP LEU LYS ASP SEQRES 61 A 965 LYS ASN LYS GLY GLU ILE TYR ASP ALA ALA ILE ASP LEU SEQRES 62 A 965 PHE THR ARG SER CYS ALA GLY TYR CYS VAL ALA THR PHE SEQRES 63 A 965 ILE LEU GLY ILE GLY ASP ARG HIS ASN SER ASN ILE MET SEQRES 64 A 965 VAL LYS ASP ASP GLY GLN LEU PHE HIS ILE ASP PHE GLY SEQRES 65 A 965 HIS PHE LEU ASP HIS LYS LYS LYS LYS PHE GLY TYR LYS SEQRES 66 A 965 ARG GLU ARG VAL PRO PHE VAL LEU THR GLN ASP PHE LEU SEQRES 67 A 965 ILE VAL ILE SER LYS GLY ALA GLN GLU CYS THR LYS THR SEQRES 68 A 965 ARG GLU PHE GLU ARG PHE GLN GLU MET CYS TYR LYS ALA SEQRES 69 A 965 TYR LEU ALA ILE ARG GLN HIS ALA ASN LEU PHE ILE ASN SEQRES 70 A 965 LEU PHE SER MET MET LEU GLY SER GLY MET PRO GLU LEU SEQRES 71 A 965 GLN SER PHE ASP ASP ILE ALA TYR ILE ARG LYS THR LEU SEQRES 72 A 965 ALA LEU ASP LYS THR GLU GLN GLU ALA LEU GLU TYR PHE SEQRES 73 A 965 MET LYS GLN MET ASN ASP ALA HIS HIS GLY GLY TRP THR SEQRES 74 A 965 THR LYS MET ASP ALA ALA ALA HIS THR ILE LYS GLN HIS SEQRES 75 A 965 ALA LEU ASN SEQRES 1 B 180 GLY MET ALA ALA ALA GLY TRP ARG ASP GLY SER GLY GLN SEQRES 2 B 180 GLU LYS TYR ARG LEU VAL VAL VAL GLY GLY GLY GLY VAL SEQRES 3 B 180 GLY LYS SER ALA LEU THR ILE GLN PHE ILE ALA SER TYR SEQRES 4 B 180 PHE VAL THR ASP TYR ASP PRO THR ILE GLU ASP SER TYR SEQRES 5 B 180 THR LYS GLN CYS VAL ILE ASP ASP ARG ALA ALA ARG LEU SEQRES 6 B 180 ASP ILE LEU ASP THR ALA GLY GLN GLU GLU PHE GLY ALA SEQRES 7 B 180 MET ARG GLU GLN TYR MET ARG THR GLY GLU GLY PHE LEU SEQRES 8 B 180 LEU VAL PHE SER VAL THR ASP ARG GLY SER PHE GLU GLU SEQRES 9 B 180 ILE TYR LYS PHE GLN ARG GLN ILE LEU ARG VAL LYS ASP SEQRES 10 B 180 ARG ASP GLU PHE PRO MET ILE LEU ILE GLY ASN LYS ALA SEQRES 11 B 180 ASP LEU ASP HIS GLN ARG GLN VAL THR GLN GLU GLU GLY SEQRES 12 B 180 GLN GLN LEU ALA ARG GLN LEU LYS VAL THR TYR MET GLU SEQRES 13 B 180 ALA SER ALA LYS ILE ARG MET ASN VAL ASP GLN ALA PHE SEQRES 14 B 180 HIS GLU LEU VAL ARG VAL ILE ARG LYS PHE GLN HET 5H5 A1101 28 HET GNP B 201 32 HET MG B 202 1 HETNAM 5H5 (2S)-2-({2-[1-(PROPAN-2-YL)-1H-1,2,4-TRIAZOL-5-YL]-5,6- HETNAM 2 5H5 DIHYDROIMIDAZO[1,2-D][1,4]BENZOXAZEPIN-9-YL}OXY) HETNAM 3 5H5 PROPANAMIDE HETNAM GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER HETNAM MG MAGNESIUM ION HETSYN 5H5 GDC-0326 FORMUL 3 5H5 C19 H22 N6 O3 FORMUL 4 GNP C10 H17 N6 O13 P3 FORMUL 5 MG MG 2+ HELIX 1 AA1 GLU A 109 GLY A 122 1 14 HELIX 2 AA2 VAL A 125 MET A 130 1 6 HELIX 3 AA3 ASP A 133 ILE A 143 1 11 HELIX 4 AA4 ILE A 143 ASP A 152 1 10 HELIX 5 AA5 PRO A 159 TYR A 167 1 9 HELIX 6 AA6 PRO A 178 ASN A 183 1 6 HELIX 7 AA7 LYS A 184 LYS A 187 5 4 HELIX 8 AA8 VAL A 216 ARG A 230 1 15 HELIX 9 AA9 GLN A 238 LEU A 244 1 7 HELIX 10 AB1 GLU A 245 GLN A 247 5 3 HELIX 11 AB2 PRO A 266 GLN A 269 5 4 HELIX 12 AB3 TYR A 270 GLY A 280 1 11 HELIX 13 AB4 LYS A 290 SER A 295 1 6 HELIX 14 AB5 SER A 326 ILE A 330 5 5 HELIX 15 AB6 PRO A 394 LEU A 396 5 3 HELIX 16 AB7 ASP A 488 ARG A 502 1 15 HELIX 17 AB8 ARG A 524 THR A 536 1 13 HELIX 18 AB9 THR A 544 HIS A 554 1 11 HELIX 19 AC1 ILE A 561 GLU A 563 5 3 HELIX 20 AC2 ILE A 564 LEU A 570 1 7 HELIX 21 AC3 ASP A 578 ASP A 589 1 12 HELIX 22 AC4 LYS A 594 MET A 599 1 6 HELIX 23 AC5 GLU A 600 ASP A 603 5 4 HELIX 24 AC6 ASP A 608 GLU A 620 1 13 HELIX 25 AC7 THR A 624 TYR A 631 1 8 HELIX 26 AC8 TYR A 631 VAL A 638 1 8 HELIX 27 AC9 ASN A 647 LEU A 658 1 12 HELIX 28 AD1 ASN A 660 SER A 673 1 14 HELIX 29 AD2 VAL A 680 CYS A 695 1 16 HELIX 30 AD3 MET A 697 GLN A 721 1 25 HELIX 31 AD4 LYS A 729 ARG A 740 1 12 HELIX 32 AD5 ARG A 741 ASP A 746 1 6 HELIX 33 AD6 ALA A 747 GLN A 749 5 3 HELIX 34 AD7 LEU A 807 ASN A 826 1 20 HELIX 35 AD8 THR A 876 ASN A 885 1 10 HELIX 36 AD9 GLU A 888 GLY A 912 1 25 HELIX 37 AE1 THR A 957 SER A 965 1 9 HELIX 38 AE2 THR A 974 HIS A 994 1 21 HELIX 39 AE3 HIS A 994 MET A 1004 1 11 HELIX 40 AE4 MET A 1005 GLY A 1009 5 5 HELIX 41 AE5 SER A 1015 LEU A 1026 1 12 HELIX 42 AE6 THR A 1031 HIS A 1047 1 17 HELIX 43 AE7 GLY B 26 ALA B 36 1 11 HELIX 44 AE8 PHE B 75 ALA B 77 5 3 HELIX 45 AE9 MET B 78 GLY B 86 1 9 HELIX 46 AF1 ASP B 97 GLU B 102 1 6 HELIX 47 AF2 GLU B 103 ASP B 116 1 14 HELIX 48 AF3 LEU B 131 ARG B 135 5 5 HELIX 49 AF4 THR B 138 LYS B 150 1 13 HELIX 50 AF5 ASN B 163 LYS B 177 1 15 SHEET 1 AA1 4 LYS A 204 ASN A 212 0 SHEET 2 AA1 4 GLN A 189 ILE A 197 -1 N ILE A 190 O ILE A 211 SHEET 3 AA1 4 ASN A 284 ALA A 289 1 O LEU A 287 N TRP A 195 SHEET 4 AA1 4 TYR A 250 VAL A 254 -1 N LYS A 253 O MET A 286 SHEET 1 AA2 4 ARG A 382 TYR A 392 0 SHEET 2 AA2 4 ALA A 333 ALA A 341 -1 N ILE A 336 O LEU A 387 SHEET 3 AA2 4 CYS A 472 PHE A 477 -1 O GLU A 476 N LYS A 337 SHEET 4 AA2 4 GLY A 439 ASN A 444 -1 N GLY A 439 O PHE A 477 SHEET 1 AA3 3 GLU A 365 PRO A 366 0 SHEET 2 AA3 3 ILE A 354 HIS A 362 -1 N HIS A 362 O GLU A 365 SHEET 3 AA3 3 VAL A 371 ASN A 372 -1 O VAL A 371 N THR A 358 SHEET 1 AA4 5 GLU A 365 PRO A 366 0 SHEET 2 AA4 5 ILE A 354 HIS A 362 -1 N HIS A 362 O GLU A 365 SHEET 3 AA4 5 ARG A 401 SER A 408 -1 O CYS A 403 N GLY A 359 SHEET 4 AA4 5 CYS A 420 ASN A 428 -1 O GLY A 425 N LEU A 404 SHEET 5 AA4 5 TRP A 446 PRO A 447 -1 O TRP A 446 N TRP A 424 SHEET 1 AA5 2 PHE A 751 LEU A 752 0 SHEET 2 AA5 2 GLN A 760 LEU A 761 -1 O LEU A 761 N PHE A 751 SHEET 1 AA6 5 ARG A 770 ILE A 771 0 SHEET 2 AA6 5 LEU A 779 GLU A 784 -1 O TRP A 780 N ARG A 770 SHEET 3 AA6 5 ASN A 796 PHE A 801 -1 O ILE A 799 N LEU A 781 SHEET 4 AA6 5 VAL A 845 GLU A 849 -1 O ILE A 848 N ILE A 800 SHEET 5 AA6 5 CYS A 838 ILE A 841 -1 N ILE A 841 O VAL A 845 SHEET 1 AA7 3 SER A 854 THR A 856 0 SHEET 2 AA7 3 ILE A 921 LYS A 924 -1 O VAL A 923 N HIS A 855 SHEET 3 AA7 3 LEU A 929 HIS A 931 -1 O PHE A 930 N MET A 922 SHEET 1 AA8 6 GLU B 48 GLN B 54 0 SHEET 2 AA8 6 ARG B 63 THR B 69 -1 O ILE B 66 N TYR B 51 SHEET 3 AA8 6 LYS B 14 GLY B 21 1 N TYR B 15 O ASP B 65 SHEET 4 AA8 6 GLY B 88 SER B 94 1 O GLY B 88 N VAL B 18 SHEET 5 AA8 6 MET B 122 ASN B 127 1 O ASN B 127 N PHE B 93 SHEET 6 AA8 6 THR B 152 GLU B 155 1 O THR B 152 N LEU B 124 LINK OG SER B 28 MG MG B 202 1555 1555 2.10 LINK OG1 THR B 46 MG MG B 202 1555 1555 1.99 LINK O2G GNP B 201 MG MG B 202 1555 1555 2.29 LINK O2B GNP B 201 MG MG B 202 1555 1555 1.94 CRYST1 181.488 181.488 96.030 90.00 90.00 90.00 P 42 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005510 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005510 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010413 0.00000